Cadila Healthcare informs about press release

09 Sep 2021 Evaluate
Cadila Healthcare has informed that it enclosed a copy of press release dated September 9, 2021 titled ‘Zydus Cadila receives tentative approval from USFDA for Brexpiprazole Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

933.40 -26.15 (-2.73%)
24-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1486.35
Dr. Reddys Lab 5962.50
Cipla 1400.00
Zydus Lifesciences 933.40
Lupin 1580.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.